¶¶زُ¶جتسئµ

header-logo
¶¶زُ¶جتسئµ Pharmacy School Logo White Medical School
Matthew Stanton, PharmD, BCPS, DABAT

Matthew Stanton, PharmD, BCPS, DABAT

Clinical Associate Professor, Department of Clinical Sciences

Locations

  • ¶¶زُ¶جتسئµ Pharmacy School
    HRC H2600

Contact Information

Education

PharmD, Midwestern University College of Pharmacy-Glendale, Glendale, AZ
BS, Bacteriology, University of Wisconsin
Pharmacy Practice Residency, Froedtert & the ¶¶زُ¶جتسئµ

Certifications

Board Certification in Pharmacotherapy Specialty (BCPS), Board of Pharmacy Specialties
Board Certified in Clinical Toxicology, American Board of Applied Toxicology
Collaborative Institutional Training Initiative (CITI) Certification, ¶¶زُ¶جتسئµ
Advanced Cardiac Life Support, American Heart Association
Basic Disaster Life Support, National Disaster Life Support Foundation
Basic Hazmat Life Support, University of Arizona
Registered Pharmacist: Wisconsin

Biography

Matthew Stanton, PharmD, BCPS, DABAT, is an emergency medicine pharmacist at Froedtert Hospital and clinical toxicologist at the Wisconsin Poison Center. Dr. Stanton received his Bachelor of Science in Bacteriology from the University of Wisconsin and Doctor of Pharmacy from Midwestern University College of Pharmacy-Glendale. He completed his pharmacy practice residency at Froedtert Hospital and became board certified in pharmacotherapy in 2010. Dr. Stanton practiced in critical care before transitioning to emergency medicine in 2012. He began practicing at the Wisconsin Poison Center in 2014 as a specialist in poison information before becoming board certified in clinical toxicology in 2016. Dr. Stanton is a Diplomate of the American Board of Applied Toxicology and also a contributing author on the Academic Life in EM University’s Capsules series.

Research Experience

  • Brown Recluse Spider
  • Drug Therapy
  • Drug-induced QT prolongation
  • Emergency Medicine
  • Forensic Toxicology
  • Poison Control Centers
  • Poisoning
  • Snake Bites
  • Spider Venoms
  • Toxicology

Clinical Expertise

  • Advanced Cardiac Life Support
  • Antimicrobial Stewardship
  • Cardiopulmonary Resuscitation
  • Critical Care
  • Disaster Medicine
  • Drug Therapy
  • Emergency Medicine
  • Forensic Toxicology
  • Hazardous Substances
  • Mass Casualty Incidents
  • Pesticides
  • Snake Bites

Educational Expertise

  • Faculty, Pharmacy
  • Pharmacy Service, Hospital

Research Interests

  • Pharmaceutical poisoning
  • Toxicology of animals, plants and microbials
  • Forensic toxicology
  • Laboratory analysis of xenobiotics

Publications

  • (Spellberg B, Wald-Dickler N, Holtom P, Meyer-Sautter P, Camp A, Diaz AD, Buhamad R, Vazquez ASM, Aguirre-Garcia GM, Stanton M, Butler-Wu SM, Chiu I, Ergenc Z, Bhoojhawon G, Murri R, Maraolo AE, Cabanilla G, Riccardi N, Tshisevhe V, Behenna C, Williams KS, Kufel WD, Wojciaczyk N, Pimentel BV, Muyidi A, Costa RP, Motta F, Bortolussi-Courval É, Lee TC, McDonald E, Ghanem B, Nelson Z.) Antimicrob Agents Chemother. 2025 Aug 06;69(8):e0051325 PMID: 40689788 PMCID: PMC12326958 07/21/2025

  • (Cicci CD, Theobald J, Stanton M, Feldman R.) Clin Toxicol (Phila). 2025 Jul;63(7):488-494 PMID: 40511470 SCOPUS ID: 2-s2.0-105009524310 06/13/2025

  • (Feldman R, Lund J, Pescatore JR, Stanton M.) Am J Health Syst Pharm. 2025 Jun 03 PMID: 40459339 06/03/2025

  • (Fox H, Jansen A, Theobald J, Stanton M, Feldman R.) Am J Emerg Med. 2025 Jan;87:70-73 PMID: 39509998 SCOPUS ID: 2-s2.0-85208142108 11/13/2024

  • (Feldman R, Theobald J, Stanton M, Stolbach A, Tormoehlen L.) Neurology. 2024 May 14;102(9):e209363 PMID: 38648601 SCOPUS ID: 2-s2.0-85191498478 04/23/2024

  • (Feldman R, Stanton M, Corcoran J, Bialkowski K, Theobald J, Gummin D.) Clin Toxicol (Phila). 2024 Mar;62(3):207-209 PMID: 38525877 SCOPUS ID: 2-s2.0-85188549470 03/25/2024

  • (Idowu D, Gray Z, Stanton M, Rushton W, Gummin D.) J Med Toxicol. 2024 Jan;20(1):49-53 PMID: 37843802 PMCID: PMC10774239 SCOPUS ID: 2-s2.0-85174255065 10/16/2023

  • (Sharpe AR, Richardson K, Stanton M, Dang C, Feih J, Brazauskas R, Teng BQ, Feldman R.) J Emerg Med. 2023 Sep;65(3):e209-e220 PMID: 37635036 SCOPUS ID: 2-s2.0-85169781378 08/28/2023

  • (O'Keefe M, Stanton M, Feldman R, Theobald J.) Clin Toxicol (Phila). 2023 Jul;61(7):536-542 PMID: 37427892 SCOPUS ID: 2-s2.0-85164747657 07/10/2023

  • (Stanton M, Feldman R, Gummin D.) Clin Toxicol (Phila). 2023 Jan;61(1):88-89 PMID: 36484497 SCOPUS ID: 2-s2.0-85143643212 12/10/2022

  • (Wells L, Stanton M, Gummin DD, Brooks M, Feldman R.) Clin Toxicol (Phila). 2022 Sep;60(9):1078-1079 PMID: 35894638 SCOPUS ID: 2-s2.0-85135010929 07/28/2022

  • (Stanton MT.) JACCP Journal of the American College of Clinical Pharmacy. December 2022;5(12):1332-1337 SCOPUS ID: 2-s2.0-85144280271 12/01/2022

Publications of from the

My teaching philosophy revolves around practical and logistical application of academic material to the patient. While I understand the foundation and fundamentals of academic learning, I find it valuable to apply textbook material to the realities of direct patient contact. I engage students to understand the rationale behind all aspects of the medical continuum and not focus only on medicines.

Matthew Stanton, PharmD, BCPS, DaBAT

© 2025 ¶¶زُ¶جتسئµ.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The ¶¶زُ¶جتسئµ (¶¶زُ¶جتسئµ) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. ¶¶زُ¶جتسئµ maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

¶¶زُ¶جتسئµ's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the ¶¶زُ¶جتسئµ community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.